Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Against the trial’s posted results

• Same as the trial’s posted resultThis paper HR 0.94 (0.89–0.99)Posted, primary outcome HR 0.94 (0.89–0.99), p = 0.016Time to First Occurrence of Cardiovascular Death, Major Coronary Event, or Non-fatal Stroke (Kaplan-Meier Estimate of Percentage of Participants Experiencing a Qualifying Event)